A Multinational Phase III Study of CS-8958 (MARVEL)

Clinical trial NCT00803595 · COMPLETED

Trial details

NCT number: NCT00803595
Sponsor: Daiichi Sankyo Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2008-11-01
Primary completion: 2009-03-01
Enrollment: 1002

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.